NCT04833582 A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With Osteosarcoma Status COMPLETED Phase PHASE1
NCT04803877 SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04758000 Metformin as Maintenance Therapy in Patients With Bone Sarcoma and High Risk of Relapse Status RECRUITING Phase PHASE2
NCT04735289 Dietary Habits, Metabolome, Immune Profile and Microbiota in Patients With Bone Sarcoma Status UNKNOWN Phase N/A
NCT04698785 Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients Status RECRUITING Phase PHASE2
NCT04671693 A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. Status ACTIVE_NOT_RECRUITING Phase NA
NCT04616560 Trastuzumab Deruxtecan for the Treatment of HER2+ Newly Diagnosed or Recurrent Osteosarcoma Status SUSPENDED Phase PHASE2
NCT04571229 Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma Status AVAILABLE Phase N/A
NCT04483778 B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT04461223 Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR Status UNKNOWN Phase N/A
NCT04417062 Olaparib With Ceralasertib in Recurrent Osteosarcoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04383288 ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the Extremities Status COMPLETED Phase N/A
NCT04351308 Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade Osteosarcoma Status UNKNOWN Phase PHASE2
NCT04319874 Phase II Clinical Trial Scheme of Ganoderma Lucidum Spore Powder for Postoperative Chemotherapy of Osteosarcoma Status UNKNOWN Phase PHASE2
NCT04316091 A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With Osteosarcoma Status UNKNOWN Phase PHASE1
NCT04294511 Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of Osteosarcoma Status UNKNOWN Phase PHASE2
NCT04282044 Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies Status RECRUITING Phase PHASE1